<?xml version="1.0" encoding="UTF-8"?>
<p>Zika virus (ZIKV) spread in the Americas has been linked to unique severe adverse outcomes such as fetal loss [
 <xref rid="pntd.0008285.ref001" ref-type="bibr">1</xref>], congenital Zika syndrome (CZS) [
 <xref rid="pntd.0008285.ref002" ref-type="bibr">2</xref>], Guillain-Barré syndrome (GBS) [
 <xref rid="pntd.0008285.ref003" ref-type="bibr">3</xref>], and rare cases of encephalopathy [
 <xref rid="pntd.0008285.ref004" ref-type="bibr">4</xref>], meningoencephalitis [
 <xref rid="pntd.0008285.ref005" ref-type="bibr">5</xref>], myelitis [
 <xref rid="pntd.0008285.ref006" ref-type="bibr">6</xref>], uveitis [
 <xref rid="pntd.0008285.ref007" ref-type="bibr">7</xref>], and severe thrombocytopenia [
 <xref rid="pntd.0008285.ref008" ref-type="bibr">8</xref>]. ZIKV is mainly transmitted through the bite of 
 <italic>Aedes aegypti</italic>, the same vector implicated in dengue (DENV) infection but there are however other routes of infection including sexual contact [
 <xref rid="pntd.0008285.ref009" ref-type="bibr">9</xref>–
 <xref rid="pntd.0008285.ref011" ref-type="bibr">11</xref>] and vertical transmission [
 <xref rid="pntd.0008285.ref012" ref-type="bibr">12</xref>–
 <xref rid="pntd.0008285.ref014" ref-type="bibr">14</xref>] that increase the spread of the virus. ZIKV and DENV circulate on same geographic areas [
 <xref rid="pntd.0008285.ref015" ref-type="bibr">15</xref>, 
 <xref rid="pntd.0008285.ref016" ref-type="bibr">16</xref>] posing a challenge in different areas like diagnosis, epidemiology, vaccine design and pathogenesis.
</p>
